No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Esaote Enters The World Of Total Body MRI With Magnifico Open

Latest-generation open MRI for excellent diagnostic quality, patient comfort and low operating costs. Magnifico Open enriches the range of Esaote products presented in 2021.

Editor: What To Know

  • At Esaote we have been working for over 30 years in the MRI sector to reach ever new horizons and 2021 is for us a year with a wealth of new products, confirming our constant commitment to innovation and the development of cutting-edge technologies,” commented Franco Fontana, Esaote CEO.
  • Magnifico Open is equipped with most recent Esaote technologies like Speed Up, to assure optimal image quality in reduced examination times, True-Motion real-time imaging, offering a complementary approach to standard MRI for a more comprehensive clinical and diagnostic picture, particularly in high-level sports medicine, or MAR (Metal Artifact Reduction) allowing excellent image quality also for post-surgical imaging.
  • Esaote, a leading Italian company in the biomedical sector—in ultrasound, dedicated magnetic resonance imaging, and information technology for healthcare— enters the world of total body magnetic resonance imaging with the new system called “Magnifico Open”.

Esaote, a leading Italian company in the biomedical sector—in ultrasound, dedicated magnetic resonance imaging, and information technology for healthcare— enters the world of total body magnetic resonance imaging with the new system called “Magnifico Open”.

Magnifico Open comes forth out of Esaote’s over 30 years of MRI experience. With Magnifico Open, Esaote proposes an open MRI system with cutting-edge technology to satisfy not only the clinical needs but also addressing operational and financial demands. An ample choice of receiving coils and state-of-the-art MRI technology offers the user an excellent image quality whereas the permanent magnet makes for simple installation and low operating costs.  The open magnet and easy-to-access patient table facilitate fast and comfortable patient positioning, ideal for claustrophobic patients and children alike.

Magnifico Open is equipped with most recent Esaote technologies like Speed Up, to assure optimal image quality in reduced examination times, True-Motion real-time imaging, offering a complementary approach to standard MRI for a more comprehensive clinical and diagnostic picture, particularly in high-level sports medicine, or MAR (Metal Artifact Reduction) allowing excellent image quality also for post-surgical imaging. Magnifico Open  aims to become the gold standard in the field of open Magnetic Resonance Imaging.

“In recent years, the technological evolution of MRI has seen major developments. At Esaote we have been working for over 30 years in the MRI sector to reach ever new horizons and 2021 is for us a year with a wealth of new products, confirming our constant commitment to innovation and the development of cutting-edge technologies,” commented Franco Fontana, Esaote CEO. “Today with Magnifico Open we are looking even more toward the future. With our experience and thanks to continual cooperation with many medical and scientific partners, we are entering the field of full body magnetic resonance imaging. This is an important achievement, which fills us with pride and opens us to new challenges.”

Magnifico Open is to be presented on Friday, 8 October 2021 with an exclusive streaming event on several platforms. The event, part of the Esaote “Exploring the Inside” program, is dedicated to the theme of the Challenge. The event is going to be hosted by illustrious figures such as the professional apneist Umberto Pellizzari and distinguished medical experts. https://www.mri-magnifico.com/

Other Esaote news here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy